The scope of the USE-BNP Trial is to investigate whether knowledge of BNP measurements, in conjunction with clinical assessment, in the outpatient setting can guide the management of therapy in patients with heart failure.
Study Type
OBSERVATIONAL
Enrollment
108
Diagnostic test
no intervention
Palo Alto VA Health Care System
Palo Alto, California, United States
Bellevue Hospital
New York, New York, United States
The Hudson Valley Heart Center
Poughkeepsie, New York, United States
composite endpoint of all cause mortality, hospitalization due to worsening heart failure and administration of IV drug therapy for worsening heart failure.
Time frame: 12 months
NYHA classifications in the two treatment groups
Time frame: 12 months
Quality of life assessments of two treatment groups
Time frame: 12 months
change in therapy based on BNP usage
Time frame: 12 months
number of serious adverse events for the two groups
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
UT Southwestern Medical Center
Dallas, Texas, United States
Virginia Research Institute
Danville, Virginia, United States
Centre Hospitalier Universitaire de Sherbrooke
Fleurimont, Quebec, Canada
Centre Hospitalier de l'Université de Montréal (CHUM) Hôpital Hôtel Dieu
Montreal, Quebec, Canada
McGill University Health Centre (MUHC) Royal Victoria Hospital
Montreal, Quebec, Canada
McGill University Health Centre (MUHC) Montreal General Hospital
Montreal, Quebec, Canada
...and 1 more locations